全文获取类型
收费全文 | 23595篇 |
免费 | 1344篇 |
国内免费 | 97篇 |
专业分类
耳鼻咽喉 | 248篇 |
儿科学 | 529篇 |
妇产科学 | 511篇 |
基础医学 | 4255篇 |
口腔科学 | 510篇 |
临床医学 | 1688篇 |
内科学 | 3940篇 |
皮肤病学 | 694篇 |
神经病学 | 2443篇 |
特种医学 | 1853篇 |
外科学 | 2699篇 |
综合类 | 101篇 |
一般理论 | 9篇 |
预防医学 | 1752篇 |
眼科学 | 221篇 |
药学 | 2069篇 |
中国医学 | 130篇 |
肿瘤学 | 1384篇 |
出版年
2023年 | 157篇 |
2022年 | 275篇 |
2021年 | 665篇 |
2020年 | 381篇 |
2019年 | 495篇 |
2018年 | 674篇 |
2017年 | 508篇 |
2016年 | 602篇 |
2015年 | 579篇 |
2014年 | 773篇 |
2013年 | 1046篇 |
2012年 | 1759篇 |
2011年 | 2159篇 |
2010年 | 1106篇 |
2009年 | 685篇 |
2008年 | 1573篇 |
2007年 | 1772篇 |
2006年 | 1623篇 |
2005年 | 1437篇 |
2004年 | 1338篇 |
2003年 | 1200篇 |
2002年 | 1083篇 |
2001年 | 451篇 |
2000年 | 541篇 |
1999年 | 351篇 |
1998年 | 180篇 |
1997年 | 151篇 |
1996年 | 101篇 |
1995年 | 112篇 |
1994年 | 73篇 |
1993年 | 56篇 |
1992年 | 63篇 |
1991年 | 61篇 |
1990年 | 66篇 |
1989年 | 39篇 |
1988年 | 52篇 |
1987年 | 34篇 |
1986年 | 39篇 |
1985年 | 51篇 |
1984年 | 36篇 |
1983年 | 38篇 |
1982年 | 40篇 |
1981年 | 41篇 |
1980年 | 33篇 |
1979年 | 35篇 |
1978年 | 39篇 |
1976年 | 26篇 |
1975年 | 36篇 |
1974年 | 26篇 |
1973年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 343 毫秒
981.
Marina Taloyan Shakila Momtaz Kristin Steiner Claes-Göran Östenson Helena Salminen 《Primary Care Diabetes》2021,15(3):522-527
BackgroundA painful burning sensation in the feet is a common problem. The most common cause is small fibre neuropathy, a type of peripheral neuropathy that is often a consequence of diabetes and prediabetes.AimTo examine the association between a self-reported burning sensation in the feet and HbA1c levels in primary healthcare patients.MethodsThis study used data from patients in the 4D diabetes project in Swedish primary healthcare. The study population included 824 patients. Logistic regression was performed to study the association between the outcome and explanatory variables.ResultsA total of 24% of patients reported a burning sensation in the feet. This sensation was not associated with HbA1c levels. However, the probability of reporting a burning sensation was two times higher in non-Swedish-born than Swedish-born patients (OR, 2.31; 95% CI, 1.55–3.44) and higher in smokers than those who had never smoked, regardless of region of birth (OR, 1.69; 95% CI, 1.07?2.65).ConclusionsOur results do not support the hypothesis that a self-reported burning sensation in the feet is associated with HbA1c levels. Rather, they indicate a strong relationship between a burning sensation and region of birth, as well as between a burning sensation and smoking. 相似文献
982.
Batyraliev TA Pershukov IV Niyazova-Karben ZA Karaus A Calenici O Guler N Eryonucu B Temamogullari A Ozgul S Akgul F Sengul H Dogru O Demirbas O Timoshin IS Gaigukov AV Petrakova LN Peresypko MK Sidorenko BA;International Invasive Cardiology Research Group 《Angiology》2006,57(1):21-32
Treatment of in-stent restenosis (ISR) with conventional percutaneous transluminal coronary angioplasty (PTCA) causes significant recurrent neointimal tissue growth in 30-85%. Therefore, laser ablation of intrastent neointimal hyperplasia before balloon dilation can be an attractive alternative. However, the long-term outcomes of such treatment have not been studied thoroughly enough. This prospective case-control study evaluated angiographic and clinical outcomes of PTCA alone and a combination of excimer laser coronary angioplasty (ELCA) and adjunct PTCA in 125 patients with ISR. ELCA was performed before balloon dilation in 67 patients, PTCA alone was performed in 58 patients. Basic demographic and clinical data were comparable in both groups. Lesions included in ELCA group were longer (17.1+/-9.9 vs 13.6+/-9.1 mm; p = 0.034), more complex (36.5% type C stenoses vs 14.3%; p = 0.006), and more frequently had reduced distal blood flow (TIMI <3: 18.9% vs 4.8%; p = 0.025) compared to lesions in the PTCA group. Immediate angiographic results of PTCA and ELCA + PTCA appeared to be comparable. PTCA alone was successful in 57 patients (98.3%), ELCA + PTCA, in 66 patients (98.5%). The rates of hospital complications were comparable (3.0% in ELCA group vs 8.6% in PTCA group). The 1-year follow-up showed that the rates of major adverse cardiac events (MACE) were comparable in the 2 groups (37.3% in ELCA group vs 46.6% in PTCA group). The rates of target vessel revascularization (TVR) within 1 year after the intervention were also similar in the 2 groups (32.8% vs 34.5%). The data mean that ELCA in patients with complex ISR is efficient and safe. Despite a higher complexity of lesions in the ELCA group, no increase in the rate of complications was registered. 相似文献
983.
Jennifer M. Kalish Leslie G. Biesecker Frederic Brioude Matthew A. Deardorff Alessandra Di Cesare‐Merlone Todd Druley Giovanni B. Ferrero Pablo Lapunzina Lidia Larizza Saskia Maas Marina Macchiaiolo Eamonn R. Maher Silvia Maitz Julian A. Martinez‐Agosto Alessandro Mussa Peter Robinson Silvia Russo Angelo Selicorni Raoul C. Hennekam 《American journal of medical genetics. Part A》2017,173(7):1735-1738
984.
Alessio Coi Michele Santoro Ester Garne Anna Pierini Marie‐Claude Addor Jean‐Luc Alessandri Jorieke E. H. Bergman Fabrizio Bianchi Ljubica Boban Paula Braz Clara Cavero‐Carbonell Miriam Gatt Martin Haeusler Kari Klungsøyr Jennifer J. Kurinczuk Monica Lanzoni Nathalie Lelong Karen Luyt Olatz Mokoroa Carmel Mullaney Vera Nelen Amanda J. Neville Mary T. O'Mahony Isabelle Perthus Judith Rankin Anke Rissmann Florence Rouget Bruno Schaub David Tucker Diana Wellesley Katarzyna Wisniewska Nataliia Zymak‐Zakutnia Ingeborg Barišić 《American journal of medical genetics. Part A》2019,179(9):1791-1798
Achondroplasia is a rare genetic disorder resulting in short‐limb skeletal dysplasia. We present the largest European population‐based epidemiological study to date using data provided by the European Surveillance of Congenital Anomalies (EUROCAT) network. All cases of achondroplasia notified to 28 EUROCAT registries (1991–2015) were included in the study. Prevalence, birth outcomes, prenatal diagnosis, associated anomalies, and the impact of paternal and maternal age on de novo achondroplasia were presented. The study population consisted of 434 achondroplasia cases with a prevalence of 3.72 per 100,000 births (95%CIs: 3.14–4.39). There were 350 live births, 82 terminations of pregnancy after prenatal diagnosis, and two fetal deaths. The prenatal detection rate was significantly higher in recent years (71% in 2011–2015 vs. 36% in 1991–1995). Major associated congenital anomalies were present in 10% of cases. About 20% of cases were familial. After adjusting for maternal age, fathers >34 years had a significantly higher risk of having infants with de novo achondroplasia than younger fathers. Prevalence was stable over time, but regional differences were observed. All pregnancy outcomes were included in the prevalence estimate with 80.6% being live born. The study confirmed the increased risk for older fathers of having infants with de novo achondroplasia. 相似文献
985.
Wiskott‐Aldrich syndrome (WAS) is a primary immunodeficiency, which is characterized by abnormal immune system functions caused by the lack of expression of WAS protein (WASp). A higher tumor susceptibility is observed in WAS patients; whether this is a direct consequence of impaired immunosurveillance due to WAS deficiency in immune cells is, however, an open question. In this issue of the European Journal of Immunology, Catucci et al. [Eur. J. Immunol. 2014. 44: 1039‐1045] shed light on the link between Was deficiency and immunosurveillance in a tumor‐prone mouse model and report a role for the impaired crosstalk between natural killer (NK) cells and dendritic cells (DCs) in mediating this process. The potential mechanisms involved in WASp regulation of NK/DC‐mediated immunosurveillance are the focus of this Commentary. 相似文献
986.
Iris Barshack Gila Lithwick-Yanai Arnon Afek Kinneret Rosenblatt Hila Tabibian-Keissar Merav Zepeniuk Lahav Cohen Harel Dan Orit Zion Yulia Strenov Sylvie Polak-Charcon Marina Perelman 《Pathology, research and practice》2010
For surgical pathologists, distinguishing whether a pulmonary neoplasm is primary or metastatic can be challenging, and current biomarkers do not always aid lung tumor classification. The tissue-associated expression of microRNA likely explains the remarkable finding that many tumors can be classified based solely on their microRNA expression signature. Here we show that microRNAs can serve as biomarkers for lung tumor classification. Using microRNA microarray data generated from 76 formalin-fixed, paraffin-embedded (FFPE) samples of either primary lung cancer or metastatic tumors to the lung, we have identified a set of microRNAs expressed differentially between these two groups. This set includes hsa-miR-182, which was most strongly over-expressed in the lung primary tumors, and hsa-miR-126, which was over-expressed in the metastatic tumors. The differential expression of this set of microRNAs was confirmed using qRT-PCR on a set of 54 samples. In light of our data, microRNA expression should be considered as a potential clinical biomarker for surgical pathologists faced with discerning the tumor type of an inscrutable lung neoplasm. 相似文献
987.
Canon JR Roudier M Bryant R Morony S Stolina M Kostenuik PJ Dougall WC 《Clinical & experimental metastasis》2008,25(2):119-129
Bone metastases cause severe skeletal morbidity including fractures and hypercalcemia. Tumor cells in bone induce activation
of osteoclasts, which mediate bone resorption and release of growth factors from bone matrix, resulting in a “vicious cycle”
of bone breakdown and tumor proliferation. Receptor activator of NF-κB ligand (RANKL) is an essential mediator of osteoclast
formation, function, and survival, and is blocked by a soluble decoy receptor, osteoprotegerin (OPG). In human malignancies
that metastasize to bone, dysregulation of the RANK/RANKL/OPG pathway can increase the RANKL:OPG ratio, a condition which
favors excessive osteolysis. In a mouse model of bone metastasis, RANKL protein levels in MDA-MB-231 (MDA-231) tumor-bearing
bones were significantly higher than tumor-free bones. The resulting tumor-induced osteoclastogenesis and osteolysis was dose-dependently
inhibited by recombinant OPG-Fc treatment, supporting the essential role for RANKL in this process. Using bioluminescence
imaging in a mouse model of metastasis, we monitored the anti-tumor efficacy of RANKL inhibition on MDA-231 human breast cancer
cells in a temporal manner. Treatment with OPG-Fc in vivo inhibited growth of MDA-231 tumor cells in bony sites when given
both as a preventative (dosed day 0) and as a therapeutic agent for established bone metastases (dosed day 7). One mechanism
by which RANKL inhibition reduced tumor burden appears to be indirect through inhibition of the “vicious cycle” and involved
an increase in tumor cell apoptosis, as measured by active caspase-3. Here, we demonstrate for the first time that OPG-Fc
treatment of mice with established bone metastases resulted in an overall improvement in survival. 相似文献
988.
989.
Manuela Kellner Marina M. Steindorff Jürgen F. Strempel Andreas Winkel Mark P. Kühnel Meike Stiesch 《Archives of oral biology》2014
Objective
Autologous therapy via stem cell-based tissue regeneration is an aim to rebuild natural teeth. One option is the use of adult stem cells from the dental pulp (DPSCs), which have been shown to differentiate into several types of tissue in vitro and in vivo, especially into tooth-like structures. DPSCs are mainly isolated from the dental pulp of third molars routinely extracted for orthodontic reasons. Due to the extraction of third molars at various phases of life, DPSCs are isolated at different developmental stages of the tooth.Design
The present study addressed the question whether DPSCs from patients of different ages were similar in their growth characteristics with respect to the stage of tooth development. Therefore DPSCs from third molars of 12–30 year-old patients were extracted, and growth characteristics, e.g. doubling time and maximal cell division potential were analysed. In addition, pulp and hard dental material weight were recorded.Results
Irrespective of the age of patients almost all isolated cells reached 40–60 generations with no correlation between maximal cell division potential and patient age. Cells from patients <22 years showed a significantly faster doubling time than the cells from patients ≥22 years.Conclusion
The age of patients at the time of stem cell isolation is not a crucial factor concerning maximal cell division potential, but does have an impact on the doubling time. However, differences in individuals regarding growth characteristics were more pronounced than age-dependent differences. 相似文献990.